American Alpha Advisors, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 2041441 NEW YORK, NY

Position in GILD

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$573,836

-$47,754 QoQ

Shares Held

4,542

+1.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.92%

of 13F equity value

Holder Rank

#1,318

of 2,266 holders

Holding Since

Mar 2025

6 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

American Alpha Advisors, LLC holds $3,152,792 across 5 Drug Manufacturers - General names. GILD ranks #4 (18.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRK	Merck & Co., Inc.	5,707	$733,349
2	AMGN	Amgen Inc	1,839	$665,938
3	BMY	Bristol Myers Squibb Co	11,283	$650,126
4	GILD	Gilead Sciences, Inc. This page	4,542	$573,836
5	PFE	Pfizer Inc	21,991	$529,543

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$573,836	4,542	+1.8%	Shares	Sole	2026-08-14
2026-03-31	$621,590	4,460	+4.8%	Shares	Sole	2026-05-15
2025-12-31	$522,258	4,255	+18.9%	Shares	Sole	2026-02-17
2025-09-30	$397,269	3,579	-7.7%	Shares	Sole	2025-10-29
2025-06-30	$429,842	3,877	+5.8%	Shares	Sole	2025-08-07
2025-03-31	$410,551	3,664	—	Shares	Sole	2025-05-12
No filing history on record for this holder in this stock.